Virginia Secures $120 Million Investment for Pharmaceutical Manufacturing Workforce Development A $120 million investment from AstraZeneca, Eli Lilly, and Merck aims to bolster Virginia's pharmaceutical workforce through advanced training initiatives.

Virginia Secures $120 Million Investment for Pharmaceutical Manufacturing Workforce Development #United_States #Richmond #Advanced_Manufacturing #Virginia_Innovation #ABBM